Redeye updates on Evolution post Q2-results which were largely in line with our forecasts. With Asia returning to growth, the outlook for the region has become more positive, although Europe continues to perform weaker than expected. Still, the overall near-term visibility has improved somewhat and supports the company’s reiterated full year guidance and expectations of stronger performance in H2 2025.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/